CD4 and cardiomyopathy: Furthermore, the greater number of CD4+CD25− T cells of free/mild cardiomyopathy patients and Bz treated patients expressing CTLA-4 than cells from moderate/severe cardiomyopathy patients, probably contributes to the modulation of immune response in the heart.